162 related articles for article (PubMed ID: 11365137)
1. Cessation of anti-CMV therapy in patients with CMV retinitis.
Dunn JP
Hopkins HIV Rep; 1998 Mar; 10(2):11. PubMed ID: 11365137
[TBL] [Abstract][Full Text] [Related]
2. Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
Whitcup SM; Fortin E; Lindblad AS; Griffiths P; Metcalf JA; Robinson MR; Manischewitz J; Baird B; Perry C; Kidd IM; Vrabec T; Davey RT; Falloon J; Walker RE; Kovacs JA; Lane HC; Nussenblatt RB; Smith J; Masur H; Polis MA
JAMA; 1999 Nov; 282(17):1633-7. PubMed ID: 10553789
[TBL] [Abstract][Full Text] [Related]
3. Discontinuation of maintenance CMV therapy in HAART responders.
Dunn JP
Hopkins HIV Rep; 1999 May; 11(3):5. PubMed ID: 11367373
[TBL] [Abstract][Full Text] [Related]
4. CMV after HAART.
Posit Aware; 1998; 9(5):18, 23. PubMed ID: 11365888
[TBL] [Abstract][Full Text] [Related]
5. Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy.
Song MK; Karavellas MP; MacDonald JC; Plummer DJ; Freeman WR
Retina; 2000; 20(2):151-5. PubMed ID: 10783947
[TBL] [Abstract][Full Text] [Related]
6. Cytomegalovirus retinitis in advanced HIV-infected patients treated with protease inhibitors: incidence and outcome over 2 years.
Labetoulle M; Goujard C; Frau E; Rogier H; Niessen F; Furlan V; Lantz O; Lecointe D; Delfraissy JF; Offret H
J Acquir Immune Defic Syndr; 1999 Nov; 22(3):228-34. PubMed ID: 10770342
[TBL] [Abstract][Full Text] [Related]
7. Cystoid macular oedema and cytomegalovirus retinitis in patients with HIV disease treated with highly active antiretroviral therapy.
Cassoux N; Lumbroso L; Bodaghi B; Zazoun L; Katlama C; LeHoang P
Br J Ophthalmol; 1999 Jan; 83(1):47-9. PubMed ID: 10209434
[TBL] [Abstract][Full Text] [Related]
8. Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy.
Macdonald JC; Torriani FJ; Morse LS; Karavellas MP; Reed JB; Freeman WR
J Infect Dis; 1998 May; 177(5):1182-7. PubMed ID: 9593001
[TBL] [Abstract][Full Text] [Related]
9. [Cystoid macular edema and cytomegalovirus retinitis in AIDS patients treated with antiretroviral triple therapy].
Badelon I; Gohier P; Chaine G
J Fr Ophtalmol; 1999 Dec; 22(10):1034-41. PubMed ID: 10617840
[TBL] [Abstract][Full Text] [Related]
10. Protease inhibitors linked to drop in CMV retinitis.
AIDS Alert; 1997 Aug; 12(8):92-4. PubMed ID: 11364475
[TBL] [Abstract][Full Text] [Related]
11. Highly active antiretroviral therapy-related immune recovery in AIDS patients with cytomegalovirus retinitis.
Macdonald JC; Karavellas MP; Torriani FJ; Morse LS; Smith IL; Reed JB; Freeman WR
Ophthalmology; 2000 May; 107(5):877-81; discussion 881-3. PubMed ID: 10811078
[TBL] [Abstract][Full Text] [Related]
12. [Incidence and evaluation of viral retinitis in patients infected with the HIV virus and treated with HIV protease inhibitors].
Labetoulle M; Goujard C; Frau E; Rogier H; Niessen F; Rudent A; Lantz O; Lecointe D; Furlan V; Delfraissy JF; Offret H
J Fr Ophtalmol; 1998 Oct; 21(8):567-76. PubMed ID: 9833222
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
Holland GN; Vaudaux JD; Shiramizu KM; Yu F; Goldenberg DT; Gupta A; Carlson M; Read RW; Novack RD; Kuppermann BD;
Am J Ophthalmol; 2008 Jan; 145(1):12-22. PubMed ID: 18154751
[TBL] [Abstract][Full Text] [Related]
14. Management of CMV retinitis in the era of highly active antiretroviral therapy.
Jouan M; Katlama C
Int J Antimicrob Agents; 1999 Sep; 13(1):1-7. PubMed ID: 10563398
[TBL] [Abstract][Full Text] [Related]
15. Loss of cytomegalovirus (CMV) viraemia following highly active antiretroviral therapy in the absence of specific anti-CMV therapy.
Deayton J; Mocroft A; Wilson P; Emery VC; Johnson MA; Griffiths PD
AIDS; 1999 Jul; 13(10):1203-6. PubMed ID: 10416523
[TBL] [Abstract][Full Text] [Related]
16. Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients.
Tural C; Romeu J; Sirera G; Andreu D; Conejero M; Ruiz S; Jou A; Bonjoch A; Ruiz L; Arnó A; Clotet B
J Infect Dis; 1998 Apr; 177(4):1080-3. PubMed ID: 9534987
[TBL] [Abstract][Full Text] [Related]
17. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy in HIV infected patients: natural history and clinical predictors.
Lin DY; Warren JF; Lazzeroni LC; Wolitz RA; Mansour SE
Retina; 2002 Jun; 22(3):268-77. PubMed ID: 12055458
[TBL] [Abstract][Full Text] [Related]
18. CMV retinitis and the controversies associated with highly active antiretroviral therapy and the immune recovery hypothesis.
Reed JB; Morse LS
AIDS Patient Care STDS; 1998 Mar; 12(3):181-5. PubMed ID: 11361932
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus retinitis after the initiation of highly active antiretroviral therapy: a 2 year prospective study.
Mitchell SM; Membrey WL; Youle MS; Obi A; Worrell S; Gazzard BG
Br J Ophthalmol; 1999 Jun; 83(6):652-5. PubMed ID: 10340970
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
Whitcup SM
JAMA; 2000 Feb; 283(5):653-7. PubMed ID: 10665706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
